StockData

Niki BioSolutions, Inc. (NIKI) shareholders

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Ownership

Who owns Niki BioSolutions's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Kira S. Sheinerman1,515,29351.56%13D (active)Jul 20, 2026
CGY Investments Limited (“ CGY Investments ”) (1)
Joint filing with Darren Lui (“ Darren ” or “ Mr. Lui ”) (7.30%), Seng Fun Yee (“ Seng Fun ”) (7.30%)
533,575–13D (active) amendmentApr 8, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Alidad MireskandariPresident & COO20,0000.25%Nov 17, 2026
Thomas John FreeburgChief Financial Officer––Nov 12, 2026
Laura A. PhilipsDirector6,0240.07%Oct 21, 2026
Kira SheinermanDirector, 10% owner1,515,29318.61%Oct 21, 2026
Justin Che Yuen WuDirector1,8320.02%Aug 13, 2026
Douglas Wayne ArnerDirector1,0620.01%Aug 13, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Alidad Mireskandari
President & COO
Jul 22, 2026Option exercise+20,000––20,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.03%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-70.1%
From 0M shares
Short volume, 20 days
48.4%
Of volume reported to FINRA

Shares sold short, last 4 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Niki BioSolutions's stock actually held short. Settlement fails (shares not delivered on time) peaked at 25,123 shares on Sep 8, 2026 over the last 90 days.

See a number that looks wrong?